Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 22 04:00PM ET
134.83
Dollar change
+6.68
Percentage change
5.21
%
CategoryEquity - Leveraged / Inverse Asset TypeEquities (Stocks) TagsU.S. Return% 1Y-15.25% Shs Outstand Perf Week9.34%
SponsorDirexion Shares ETF Type Tagsequity Return% 3Y-63.47% Total Holdings134 Perf Month13.27%
Fund Family Bond Type Tagsbiotechnology Return% 5Y-34.34% AUM1.06B Perf Quarter87.79%
IndexS&P Biotechnology Select Industry Index Average Maturity Tagsleverage Return% 10Y NAV% Perf Half Y40.16%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year1.99%
Active/Passive Quant Type Tags- Flows% 1M-13.08% 52W Range48.40 - 155.60 Perf YTD10.54%
Dividend TTM0.42 (0.31%) ESG Type Tags- Flows% 3M-30.38% 52W High-13.35% Beta2.88
Dividend Ex-DateDec 21, 2023 Dividend Type Sector/Theme Flows% YTD-14.40% 52W Low178.56% ATR (14)9.90
Expense0.95% Structure Type Region Flows% 1Y RSI (14)59.11 Volatility6.99% 7.62%
Option/ShortYes / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.85 Prev Close128.15
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume2.93M Price134.83
SMA2012.28% SMA5014.69% SMA20030.01% Trades Volume2,481,079 Change5.21%
Feb-08-22 03:45PM
Jun-17-21 06:00AM
Apr-08-21 07:30PM
Jun-29-20 10:45AM
Jun-26-20 11:10AM
11:15AM Loading…
May-20-20 11:15AM
May-18-20 02:47PM
May-11-20 10:27AM
May-05-20 03:11PM
Feb-10-20 09:39AM
Dec-02-19 12:05PM
Nov-20-19 10:10AM
Nov-04-19 08:00AM
Sep-18-19 01:01PM
Jul-24-19 10:30AM
09:29AM Loading…
Jun-07-19 09:29AM
Jun-04-19 10:43AM
May-22-19 07:00AM
May-07-19 11:35AM
Apr-09-19 09:25AM
Apr-05-19 03:55AM
Mar-29-19 12:09PM
10:15AM
Mar-25-19 01:37PM
Mar-04-19 09:48AM
Mar-01-19 11:20AM
Feb-15-19 10:40AM
Feb-01-19 11:45AM
Jan-24-19 11:34AM
Jan-17-19 10:05AM
10:05AM Loading…
Jan-14-19 10:05AM
Jan-10-19 04:39PM
Nov-08-18 10:47AM
Nov-06-18 10:36AM
Sep-27-18 11:58AM
Jul-18-18 12:27PM
Jul-12-18 03:51PM
Jun-22-18 12:56PM
Apr-10-18 01:47PM
Feb-07-18 08:35AM
Feb-05-18 11:59AM
Jan-31-18 10:18AM
Dec-29-17 09:09AM
Nov-29-17 04:46PM
02:06PM
Nov-14-17 03:49PM
Nov-05-17 02:43PM
Oct-20-17 03:16PM
Sep-15-17 03:26PM
Sep-08-17 10:31AM
Sep-01-17 10:49AM
Aug-31-17 04:37PM
Aug-30-17 10:53AM
Jul-27-17 02:43PM
Jul-03-17 09:30AM
Jun-30-17 02:40PM
11:41AM
Jun-23-17 02:43PM
May-18-17 01:08PM
Apr-04-17 09:02AM
Mar-20-17 12:46PM
Feb-26-17 08:26PM
Feb-17-17 01:40PM
Jan-31-17 05:09PM
01:08PM
Jan-11-17 12:31PM
Jan-04-17 10:56AM
Dec-08-16 10:34AM
Nov-15-16 10:47AM
Nov-11-16 03:16PM
Nov-08-16 09:34AM
Nov-01-16 11:20AM
Oct-21-16 09:54AM
Oct-14-16 03:26PM
11:43AM
Oct-04-16 12:15AM
Oct-03-16 10:58AM
Sep-27-16 03:21PM
Aug-25-16 06:52AM
Aug-24-16 04:22PM
Aug-08-16 05:09PM
Aug-04-16 01:46PM
Jul-19-16 02:39PM
Jun-22-16 02:07PM
Jun-10-16 09:21AM
Jun-07-16 12:33AM
May-27-16 01:11PM
May-04-16 09:21PM
Apr-19-16 07:10AM
Apr-07-16 12:30PM
Apr-06-16 08:15AM
Mar-22-16 05:00PM
Mar-08-16 09:00AM
Direxion Daily S&P Biotech Bull 3X Shares seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Biotechnology Select Industry Index ("index"). The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.